Susquehanna International Group’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,318
Closed -$608K 14173
2022
Q4
$608K Buy
18,318
+4,819
+36% +$155K ﹤0.01% 7352
2022
Q3
$426K Buy
+13,499
New +$437K ﹤0.01% 8900
2022
Q1
Sell
-24,891
Closed -$592K 14387
2021
Q4
$508K Sell
24,891
-48,279
-66% -$926K ﹤0.01% 9170
2021
Q3
$1.41M Sell
73,170
-66,266
-48% -$1.32M ﹤0.01% 6659
2021
Q2
$3.09M Buy
+139,436
New +$2.96M ﹤0.01% 4954
2021
Q1
Sell
-20,085
Closed -$478K 13047
2020
Q4
$375K Sell
20,085
-44,675
-69% -$834K ﹤0.01% 8853
2020
Q3
$1.1M Sell
64,760
-53,120
-45% -$1.03M ﹤0.01% 5870
2020
Q2
$2.75M Buy
117,880
+29,018
+33% +$421K ﹤0.01% 3955
2020
Q1
$746K Buy
88,862
+57,138
+180% +$481K ﹤0.01% 6041
2019
Q4
$310K Buy
31,724
+6,053
+24% +$56.8K ﹤0.01% 7950
2019
Q3
$244K Sell
25,671
-5,066
-16% -$53.4K ﹤0.01% 8718
2019
Q2
$365K Buy
+30,737
New +$370K ﹤0.01% 7920
2018
Q1
Sell
-52,361
Closed -$775K 10448
2017
Q4
$733K Buy
52,361
+23,361
+81% +$342K ﹤0.01% 5863
2017
Q3
$415K Buy
+29,000
New +$414K ﹤0.01% 6843
2017
Q1
Sell
-65,399
Closed -$915K 10275
2016
Q4
$1.16M Sell
65,399
-8,742
-12% -$154K ﹤0.01% 5211
2016
Q3
$1.43M Sell
74,141
-12,920
-15% -$253K ﹤0.01% 4141
2016
Q2
$1.7M Sell
87,061
-26,380
-23% -$517K ﹤0.01% 3868
2016
Q1
$2.34M Buy
113,441
+20,641
+22% +$407K ﹤0.01% 3469
2015
Q4
$1.9M Buy
+92,800
New +$1.78M ﹤0.01% 4133
2015
Q3
Sell
-28,862
Closed -$527K 10380
2015
Q2
$538K Buy
+28,862
New +$535K ﹤0.01% 7494
2015
Q1
Sell
-82,268
Closed -$1.52M 10090
2014
Q4
$1.35M Buy
82,268
+47,835
+139% +$821K ﹤0.01% 5259
2014
Q3
$609K Buy
34,433
+11,054
+47% +$217K ﹤0.01% 6849
2014
Q2
$483K Buy
+23,379
New +$480K ﹤0.01% 7545
2014
Q1
Sell
-42,211
Closed -$968K 9576
2013
Q4
$1.12M Buy
+42,211
New +$1.04M ﹤0.01% 5315

Other funds holding VIVO

Susquehanna International Group's VIVO Position: Q1 2023 in Review

Susquehanna International Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,318 shares — an estimated $608K sold.

Susquehanna International Group first reported a position in VIVO in Q4 2013 and held it in 24 quarters. The position peaked at $3.09M in Q2 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Susquehanna International Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 18,318 Meridian Bioscience Inc shares in Q1 2023, an estimated $608K.
  • Susquehanna International Group first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 24 quarters.
  • Susquehanna International Group's Meridian Bioscience Inc position peaked at $3.09M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.